DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming
Xuejiao Yang(Shanghai Jiao Tong University), Yueying Wang(Changchun University of Chinese Medicine), Siqi Shang(Shanghai Jiao Tong University), Yunshuo Chen(Shanghai Jiao Tong University), Zhiyang Li(Nanjing Drum Tower Hospital), Xiao Wang(Qingdao University), Ying Yang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 12
Related Papers
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
The dual role of N6‐methyladenosine modification of RNAs is involved in human cancers
|Journal of Cellular and Molecular Medicine|2018|142